Terminology Service < Semantic Lookup Platform

All terms in HP

Label	Id	Description
Short proximal phalanx of the 3rd finger	HP_0009459	[Hypoplasia (congenital reduction in size) of the proximal phalanx of the third finger.]
positive regulation of homotypic cell-cell adhesion	GO_0034112	[Any process that activates or increases the frequency, rate, or extent of homotypic cell-cell adhesion.]
regulation of homotypic cell-cell adhesion	GO_0034110	[Any process that modulates the frequency, rate, or extent of homotypic cell-cell adhesion.]
homotypic cell-cell adhesion	GO_0034109	[The attachment of a cell to a second cell of the identical type via adhesion molecules.]
negative regulation of homotypic cell-cell adhesion	GO_0034111	[Any process that stops, prevents, or reduces the frequency, rate, or extent of homotypic cell-cell adhesion.]
visual system neuron	CL_0008028
neuron	CL_0000540	[The basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system.]
pancreatic endocrine cell	CL_0008024	[An endocrine cell that is part of the pancreas.]
endocrine cell	CL_0000163	[A cell of an endocrine gland, ductless glands that secrete substances which are released directly into the circulation and which influence metabolism and other body functions.]
myeloid cell homeostasis	GO_0002262	[The process of regulating the proliferation and elimination of myeloid cells such that the total number of myeloid cells within a whole or part of an organism is stable over time in the absence of an outside stimulus.]
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor	CHEBI_77119	[An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of prostaglandin-E2 9-reductase (EC 1.1.1.189).]
EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor	CHEBI_76835	[An EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitor that uses NAD(+) or NADP(+) as acceptor (EC 1.1.1.*).]
intracellular vesicle	GO_0097708	[Any vesicle that is part of the intracellular region.]
intracellular organelle	GO_0043229	[Organized structure of distinctive morphology and function, occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane.]
vesicle	GO_0031982	[Any small, fluid-filled, spherical organelle enclosed by membrane.]
purine ribonucleoside diphosphate metabolic process	GO_0009179	[The chemical reactions and pathways involving purine ribonucleoside diphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with diphosphate on the sugar.]
purine nucleoside diphosphate metabolic process	GO_0009135	[The chemical reactions and pathways involving purine nucleoside diphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with diphosphate on the sugar.]
ribonucleoside diphosphate metabolic process	GO_0009185	[The chemical reactions and pathways involving a ribonucleoside diphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with diphosphate on the sugar.]
vesicle targeting, trans-Golgi to periciliary membrane compartment	GO_0097712	[The process in which vesicles formed at the trans-Golgi network are directed to the plasma membrane surrounding the base of the cilium, including the ciliary pocket, mediated by molecules at the vesicle membrane and target membrane surfaces.]
vesicle targeting, to, from or within Golgi	GO_0048199	[The process in which vesicles are directed to specific destination membranes during transport to, from or within the Golgi apparatus; mediated by the addition of specific coat proteins, including COPI and COPII proteins and clathrin, to the membrane during vesicle formation.]